Advertisement
News
Subscribe to MDT Magazine News

Natural protection against radiation

May 4, 2011 12:41 pm | by EurekAlert | Comments

(American Chemical Society) In the midst of ongoing concerns about radiation exposure from the Fukushima nuclear power plant in Japan, scientists are reporting that a substance similar to resveratrol -- an antioxidant found in red wine, grapes and nuts -- could protect against...

TOPICS:

Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment

May 4, 2011 12:39 pm | by Bio-Medicine.Org | Comments

NEW YORK, May 4, 2011 /- Robotic prostatectomy and prostate cancer treatment expert Dr. David B. Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, appeared on FOX-NY's Good Day New York to...

TOPICS:

FDA Issues Final Guidance for Liquid OTC Drug Products With Dispensing Devices

May 4, 2011 12:36 pm | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., May 4, 2011/PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today released its final guidance to firms that manufacture, market, or distribute over-the-counter (OTC) liquid drug products packaged with cups, droppers, syringes, and spoons to measure and...

TOPICS:
Advertisement

EMD Serono pays out $44M to settle false claims suit

May 4, 2011 11:45 am | by Mass High Tech: The Journal of New England Technology | Comments

EMD Serono Inc., an affiliate of Merk KGaA of Germany, has paid $44.3 million and changed its Corporate Integrity Agreement as part of a civil lawsuit settlement related to allegations that the company paid health-care providers to promote its multiple sclerosis drug Rebif.

American Medical Systems' GreenLight HPS® Approved for Use in Japan

May 4, 2011 11:43 am | by Bio-Medicine.Org | Comments

MINNETONKA, Minn., May 4, 2011 /- American Medical Systems® (AMS) (NASDAQ: AMMD), a leading provider of world-class devices and therapies for male and female pelvic health, today announced it has received clearance from the Japanese Ministry of Health, Labor and Welfare (MHLW) to...

TOPICS:

Medgenics Announces Significant Shareholders Update

May 4, 2011 10:45 am | by The Associated Press | Comments

Medgenics, Inc. (NYSE Amex: MDGN) (NYSE Amex: MDGN.W) (AIM: MEDG) (AIM: MEDU), the company that has developed a novel technology for the sustained manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, reports an update to the interests of the...

Health Net reports 1Q loss due to litigation costs

May 4, 2011 9:45 am | by The Associated Press | Comments

Insurer Health Net Inc. said Wednesday that it swung to a loss for its first quarter because of litigation and restructuring costs and rising general expenses, but the company's adjusted results beat forecasts and it brightened its 2011 profit outlook.The Woodland Hills, Calif., company...

Christiana Care Breast Center First in Delaware to Earn American College of Radiology Accreditation

May 4, 2011 9:34 am | by Bio-Medicine.Org | Comments

WILMINGTON, Del., May 4, 2011 /PRNewswire-USNewswire/ -- The Christiana Care Breast Center at the Helen F. Graham Cancer Center has been awarded a three-year term of accreditation in breast Magnetic Resonance Imaging (MRI) by the American College of Radiology (ACR). (Logo:...

TOPICS:
Advertisement

Selexys Pharmaceuticals Initiates Enrollment in Phase I Clinical Study of SelG1

May 4, 2011 9:34 am | by Bio-Medicine.Org | Comments

OKLAHOMA CITY, May 4, 2011 /- Selexys Pharmaceuticals announced today that it has initiated enrollment in a Phase I clinical study of its lead compound, SelG1, a humanized anti-P-selectin antibody.   The placebo-controlled, double-blind, first-in-human, ascending single dose and...

TOPICS:

NxStage gets System One approved in Australia, New Zealand

May 4, 2011 8:48 am | by Mass High Tech: The Journal of New England Technology | Comments

NxStage Medical Inc. said it has won approval for its NxStage System One dialysis product from Australia's Therapeutic Goods Administration. In addition, the company has signed a five-year agreement with Regional Health Care Group, a medical products distributor in Australia and New Zealand.

TOPICS:

Harvard Medical School Faculty Advances Drug Safety Research With IBM Business Analytics

May 4, 2011 8:46 am | by IBM | Comments

IBM today announced that faculty from Harvard Medical School and Brigham & Women's Hospital will use IBM business analytics technology at the core of new research that examines the effectiveness of prescription drugs and spots potential safety issues. E-mail this page Save to...

Sectra nabs FDA OK for low-radiation mammography system

May 4, 2011 8:46 am | by Mass High Tech: The Journal of New England Technology | Comments

The U.S. Food and Drug Administration has approved a digital mammography system developed by Swedish IT and medical technology firm Sectra Imtec AB, which has its U.S. operations based in Shelton, Conn.

Misonix to Present at the MDB Capital Bright Lights Conference on May 11, 2011

May 4, 2011 8:44 am | by Bio-Medicine.Org | Comments

FARMINGDALE, N.Y., May 4, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and...

TOPICS:

InVivo Therapeutics, Miami Project to co-develop spinal cord injury treatments

May 4, 2011 8:41 am | by Mass High Tech: The Journal of New England Technology | Comments

InVivo Therapeutics Holdings Corp. of Cambridge and The University of Miami Miller School of Medicine's Miami Project to Cure Paralysis said today they have a strategic research collaboration to develop novel treatments for spinal cord injuries by combining their therapeutic approaches.

TOPICS:

Aires Pharmaceuticals Appoints Edwin L. Parsley as Chief Medical Officer

May 4, 2011 8:40 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 4, 2011 /- Aires Pharmaceuticals, Inc. today announced the hiring of Ed Parsley, D.O. as Chief Medical Officer.  Dr. Parsley will fill a key role on Aires' leadership team and will be responsible for all clinical development activities for Aironite™, the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading